Oramed Pharmaceuticals Inc. (ORMP) To Go Ex-Dividend on January 16th

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) announced a dividend on Wednesday, January 7th. Investors of record on Friday, January 16th will be given a dividend of 0.25 per share by the biotechnology company on Monday, January 26th. The ex-dividend date is Friday, January 16th.

Oramed Pharmaceuticals Stock Performance

Shares of NASDAQ:ORMP opened at $3.48 on Friday. Oramed Pharmaceuticals has a one year low of $1.82 and a one year high of $3.50. The stock has a market capitalization of $138.51 million, a price-to-earnings ratio of 2.76 and a beta of 1.19. The company has a 50-day simple moving average of $2.74 and a 200-day simple moving average of $2.42.

Oramed Pharmaceuticals Company Profile

Oramed Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of proprietary oral drug delivery systems, with an initial emphasis on diabetes management. Headquartered in Jerusalem, Israel, the company leverages its patented protein encapsulation technology, the “Oral Delivery Platform,” to transform injectable therapies into patient-friendly oral formulations. Oramed’s platform is designed to protect sensitive proteins and peptides from degradation in the gastrointestinal tract, enabling successful absorption and systemic delivery.

The company’s lead candidate, ORMD-0801, is an oral insulin capsule for patients with type 2 diabetes, currently advancing through Phase 3 clinical trials.